Studies have shown injection port therapy to be a safe and sometimes advantageous alternative to standard injections.
Below you will find a mix of studies and white papers that support the use of injection port therapy in those taking multiple daily injections.
This study highlights the challenges nurses face in providing a positive healthcare environment and treatment experience when administering multiple daily injections to their patients. In this study, we find the results of how patient and nursing satisfaction with the i-port® effected the use of the device in hospital settings.
This manuscript highlights the challenges associated with conventional insulin delivery and describes technologic developments that may help to overcome injection barriers and ultimately enhance glycemic control.
The purpose of this study was to assess the factors associated with the frequency of patients intentionally skipping insulin injections they know they should take. The data was obtained by an internet survey of 502 U.S. adults identified as taking insulin to treat type 1 or type 2 diabetes.
This manuscript provides a summary of patient data concerning the negative effects of taking insulin injections. Additionally, a comparison of the attitudes of both the patient and health care provider concerning those results is performed and provides the patient-provider communications concerning these issues.
The i-port® is a self-care system for those taking multiple injections to manage diabetes. This paper reviews the evidence of those using an injection port with their multiple daily injections and examine its costs and effects relative to the use of insulin pump therapy. Findings suggest that the i-port® has the potential to be a clinically viable and economically superior alternative to insulin pump therapy.
In this article, recent clinical evidence is reviewed and presented to highlight the benefits of an early and aggressive blood-glucose lowering treatment plan that incorporates multiple, daily insulin injections in people living with type 2 diabetes.
This study was performed to determine if incorporating the use of an injection port (Insuflon™) would help to improve the glycemic control in youths with type 1 diabetes.
An innovative survey called the "Injection Impact Report" was commissioned by the American Association of Diabetes Educators (AADE) to survey a group of 502 people living with diabetes and 301 healthcare professionals who treat people with diabetes. The results spotlighted patients struggling with their injections, highlighted a discrepancy in the communication between patients and their healthcare providers, and quantified the need for additional treatment options for people taking injections.
In this study, the authors report on a brief, randomized crossover study comparing the use of an injection port (i-port®) to standard multiple injection therapy.